Prevention of perinatal group B streptococcal disease. Spanish revised guidelines;Prevención de la infección perinatal por estreptococo del grupo B. Recomendaciones españolas revisadas

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 21, Issue 8, 2003, Pages 417-423

  De la Rosa, M ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LAS NIEVES   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CLINDAMYCIN; ERYTHROMYCIN; PENICILLIN DERIVATIVE; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC PROPHYLAXIS; BACTERIUM DETECTION; CHORIOAMNIONITIS; DISEASE TRANSMISSION; HUMAN; INFECTION PREVENTION; NEWBORN INFECTION; PATHOGENESIS; PRACTICE GUIDELINE; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS INFECTION; TREATMENT INDICATION;

EID: 0142027074     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13051906     Document Type: Review

References (64)

1. Sociedad Española de Obstetricia y Ginecología. Recomendaciones para la prevención de la infección perinatal por estreptococo del grupo B. Prog Obstet Gynecol 1998;41:431-5.
2. Andreu A, Sanfeliu I, Viñas L, Barranco M, Bosch J, Dopico E, et al. Declive de la Incidencia de la sepsis perinatal por estreptococo del grupo B-Barcelona 1994-2001-Relación con las políticas profilácticas. Enferm Infec Microbiol Clin 2003;21:174-9.
3. López Sastre JB, Sánchez Luna M, Fernández Colomer B, Coto Cotallo GD, and "Grupo de Hospitales Castrillo". Impact of antimicrobial prophylaxis in the epidemiology of vertical transmission sepsis. GBS neonatal disease symposium. Granada november 2002.
4. De Cueto M, de la Rosa-Fraile M. Prevención de la infección neonatal por Streptococcus agalactiae. Un tema consolidado. Enferm Infecc Microbiol Clin 2003;21:171-3.
5. Schrag S, Gorwitz R, Fultz-Butts K, Schuchat A. Prevention of perinatal group B streptococcal disease. Revised Guidelines from CDC. 2002 MMWR 51(RR11):1-22.
6. Baker CJ, Edwards MS. Streptococcus agalactiae (group B streptococcus). En: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 5th ed. New York: Churchill Livingstone, 2000; p. 2156-167.
7. Schuchat A. Group B streptococcus. Lancet 1999;353:51-6.
8. Edwards MS, Baker CJ. Group B streptococcal infections. En: Remington JS, Klein JO, editors. Infectious Diseases of the Fetus & Newborn Infant. 5th ed. Philadelphia: WB Saunders, 1999; p. 1091-156.
9. Bosch J, Pericot A, Amorós M, Ros R. Endometritis puerperal: estudio de 52 casos con diagnóstico clínico y microbioló gico. Enferm Infec Microbiol Clin 1995;13:203-8.
10. Yancey MK, Duff P, Clark P, Kurtzer T, Frentzen BH, Kubilis P. Peripartum infection associated with vaginal group B streptococcal colonization. Obstet Gynecol 1994;84:816-9.
11. Feikin DR, Thorsen P, Zywicki S, Arpi M, Westergaard JG, Schuchat A. Association between colonization with group B streptococci during pregnancy and preterm delivery among Danish women. Am J Obstet Gynecol 2001;184:427-33.
12. Matorras R, Garcia Perea A, Omeñaca F, Usandizaga JA, Nieto A, Herruzo R. Group B Streptococcus and premature rupture of membranes and preterm delivery. Gynecol Obstet Invest 1989;27:14-8.
13. Regan JA, Klebanoff MA, Nugent RP, Eschenbach DA, Blackwelder WC, Yu Lou YS, et al. Colonization with group B streptococci in pregnancy and adverse outcome. Am J Obstet Gynecol 1996;174:1354-60.
14. MØller M, Thomsen AC, Borch K, Dinesen K, Zdravkovic M. Rupture of membranes and premature delivery associated with group B streptococci in urine of pregnant women. Lancet 1984;2:69-70.
15. Juncosa T, Bosch J, Dopico E, Guardia C, Lite J, Sierra M, et al. Infección neonatal por Streptococcus agalactiae. Estudio multicéntrico en el área de Barcelona. Enf Infec Microbiol Clin 1998;16:312-5.
16. López Sastre JB, Coto Cotallo GD, Fernández Colomer B. Neonatal sepsis of vertical transmission: An epidemiological study from the "Grupo de Hospitales Castrillo". J Perinat Med 2000;28:309-15.
17. Schrag SJ, Zywicki S, Farley MM, Reingold AL, Harrison LH, Lefkowitz LB, et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. N Engl J Med 2000;342:15-20.
18. Bliss SJ, Manning SD, Tallman P, Baker CJ, Pearlman MD, Marrs CF, et al. Group B streptococcus colonization in male and nonpregnant female university students: A cross-sectional prevalence study. Clin Infect Dis 2002;15:184-90.
19. Regan JA, Klebanoff A, Nugent RP. Vaginal Infection and Prematurity Study Group. The epidemiology of group B colonization in pregnancy. Obstet Gynecol 1991;77:604-10.
20. Andreu A, Barranco M, Bosch J, Dopico E, Guardia C, Juncosa T, et al. Prevention of perinatal group B streptococcal disease in Europe. Scand J Infect Dis 1997;29:532.
21. Cueto M, Sánchez MJ, Sampedro A, Miranda JA, Herruzo AJ, Rosa-Fraile M de la. Timing of intrapartum ampicillin and prevention of vertical transmission of group B streptococcus. Obstet Gynecol 1998;91:112-4.
22. Mazon A, Salvo MS, Ezcurra R. Resultados del programa de prevención de la infección neonatal por estreptococo del grupo B. Prog Obstet Gynecol 2000;43:233-6.
23. Persson K, Bjerre B, Elfstrom L, Polberger S, Forsgren A. Group B streptococci at delivery: High counts in urine increases risk for neonatal colonization. Scand J Infect Dis 1986;18:525-31.
24. Schrag SJ, Zell ER, Lynfield R, Roome A, Arnold KE, Craig AS, et al. A population-based comparison of strategies to prevent early-onset group B streptococcal disease in neonates. N Engl J Med 2002;347:233-9.
25. Yancey MK, Schuchat A, Brown LK, Ventura VI, Markenson GR. The accuracy of late antenatal screening cultures in predicting genital group B streptococcal colonization at delivery. Obstet Gynecol 1996;88:811-5.
26. Allen UD, Navas L, King SM. Effectiveness of intrapartum penicillin prophylaxis in preventing early-onset group B streptococcal infection: Results of a meta-analysis. Can Med Assoc J 1993;149:1659-65.
27. Boyer KM, Gotoff SP. Prevention of early-onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis. N Engl J Med 1986;314:1665-9.
28. Garland SM, Fliegner JR. Group B streptococcus (GBS) and neonatal infections: The chase for intrapartum chemoprophylaxis. Aust N Z Obstet Gynaecol 1991;31:119-22.
29. Gardner SE, Yow MD, Leeds LJ, Thompson PK, Mason EO Jr, Clark DJ. Failure of penicillin to eradicate group B streptococcal colonization in the pregnant woman. A couple study. Am J Obstet Gynecol 1979;35:1062-5.
30. Hall RT, Barnes W, Krishnan L, Harris DJ, Rhodes PG, Fayez J, et al. Antibiotic treatment of parturient women colonized with group B streptococci. Am J Obstet Gynecol 1976;124:630-4.
31. Levine EM, Strom CM, Ghai V, Barton JJ. Intrapartum management relating to risk of perinatal transmission of group B streptococcus. Infect Dis Obstet Gynecol 1998;6:25-9.
32. Cueto M, Sánchez MJ, Molto L, Miranda JA, Herruzo AJ, Ruiz Bravo A, et al. Efficacy of a universal screening program for the prevention of neonatal group B streptococcal disease. Eur J Clin Microbiol Infect Dis 1995;14:810-2.
33. Gilson GJ, Christensen F, Romero H, Bekes K, Silva L, Qualls CR. Prevention of group B streptococcus early-onset neonatal sepsis: Comparison of the Center for Disease Control and prevention screening-based protocol to a risk-based protocol in infants at greater than 37 weeks' gestation. J Perinatol 2000;20:491-5.
34. Paoletti LC, Madoff LC. Vaccines to prevent neonatal GBS infection. Seminars in Neonatology 2002;7:315-23.
35. Hennequin Y, Tecco L, Vokaer A. Use of chlorhexidine during labor: How effective against neonatal group B streptococci colonization? Acta Obstet Gynaecol Scand 1995;74:168.
36. Stray-Pedersen B, Bergan T, Hafstad A, Normann E, Grogaard J, Vangdal M. Vaginal disinfection with chlorhexidine during childbirth. Int J Antimicrob Agents 1999;12:245-51.
37. Jafari HS, Schuchat A, Hilsdon R, Whitney CG, Toomey KE, Wenger JD. Barriers to prevention of perinatal Group B streptococcal disease. Pediatr Infect Dis J 1995;14:662-7.
38. Whitney CG, Plikaytis BD, Gozansky WS, Wenger JD, Schauchat A. Prevention practices for perinatal group B streptococcal disease: A multi-state surveillance analysis. Obstet Gynecol 1997;89:28-32.
39. Andreu A, Ortega E, Planes A, Salcedo S. Evolución de la sepsis perinatal por Escherichia coli en la era de la profilaxis del estreptococo de grupo B. Med Clin (Barc) 2001;117:521-4.
40. Baltimore RS, Huie SM, Meek JI, Schuchat A, O'Brien KL. Early-onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics 2001;108:1094-8.
41. Chen KT, Tuomala RE, Cohen AP, Eichenwald EC, Lieberman E. No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms. Am J Obstet Gynecol 2001;85:854-8.
42. Levine EM, Ghai V, Barton JJ, Strom CM. Intrapartum antibiotic prophylaxis increases the incidence of gram-negative neonatal sepsis. Infect Dis Obstet Gynecol 1999;7:210-3.
43. Towers CV, Carr MH, Padilla G, Asrat T. Potential consequences of widespread use of ampicillin. Am J Obstet Gynecol 1998;179:879-83.
44. Schuchat A, Zywicki SS, Dinsmoor MJ, Mercer B, Romaguera J, O'Sullivan MJ, et al. Risk factors and opportunities for prevention of early-onset neonatal sepsis: A multicenter case-control study. Pediatrics 2000;105:21-6.
45. Stoll BJ, Hansen N, Fanaroff AA, Wright LL, Carlo WA, Ehrenkranz RA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. N Engl J Med 2002;347:240-7.
46. Bosch Mestres J, Palau Charles A, Serra Azuara L, Alvarez Dominguez E, Ricart Costa MC, Ros Vallverdu R, et al. Sepsis neonatal precoz por Streptococcus agalactiae. Estudio de diez años (1985-1994) y eficacia de la profilaxis intraparto. An Esp Pediatr 1997;46:272-6.
47. Centers for Disease Control and Prevention. Group B streptococcal disease. United States, 1998-1999. MMWR 49 2000;35:793-6.
48. Jeffery HE, Moses Lahra M. Eight-year outcome of universal screening and intrapartum antibiotics for maternal group B streptococcal carriers. Pediatrics 1998;101:E2.
49. American College of Obstetrics and Gynecologists. Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion 279. December 2002. Obstetrics-Gynecology 2002;100:1405-12.
50. García Gil E, Rodríguez MC, Bartolomé R, Bejarano B, Cabero L, Andreu A. Evaluation of the Granada agar plate for detection of vaginal and rectal group B streptococci in pregnant women J Clin Microbiol 1999;37:2648-51.
51. De la Rosa M, Villarreal D, Vega D, Miranda C, Martínez Brocal A. Granada Medium for detection and identification of Group B streptococci. J Clin Microbiol 1983;18:779-85.
52. Rosa M, Pérez M, Carazo C, Peis JI, Pareja L, Hernández L. New Granada Medium for detection and Identification of group B streptococci. J Clin Microbiol 1992;30:1019-21.
53. Rosa-Fraile M, Rodriguez-Granger J, Cueto-López M, Sampedro A, Biel Gaye E, Haro JM, et al. Use of Granada Medium to detect group B streptococcal colonization in pregnant women. J Clin Microbiol 1999;37:2674-7.
54. Kaplan EL. Recent evaluation of antimicrobial resistance in b-hemolytic streptococci. Clin Infec Dis 1997:24(Suppl 1):89-92.
55. Food and Drug Administration. FDA safety alert: Risks of devices for direct detection of group B streptococcal antigen. March, 24. 1997.
56. Samadi R, Stek A, Greenspoon JS. Evaluation of a rapid optical immunoassay-based test for group B streptococcus colonization in intrapartum patients. J Matern Fetal Med 2001;10:203-8.
57. Ke D, Bergeron MG. Molecular methods for rapid detection of group B streptococci. Expert Rev Mol Diagn 2001;1:175-81.
58. Blanco Galán MA. Microbiología de la Infección Perinatal. En: Picazo JJ, editor. Procedimientos en Microbiología Clínica No. 13. Sociedad Española de Enfermedades Infecciosas y Mierobiología Clínica, 2002.
59. Mead PB. Infection of the female pelvis. En: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 5th. ed. New York: Churchill Livingstone, 2000; p. 1235-43.
60. Aracil B, Miñambres M, Oteo JC, De la Rosa M, Gomes-Garcés JL, Alos JI. Susceptibility of strains of Streptococcus agalactiae to macrolides and lincosamines, phenotypic patterns and resistance genes. Clin Microbiol Infect 2002;8:745-8.
61. Bromberger P, Lawrence JM, Braun D, Saunders B, Contreras R, Petitti DB. The influence of intrapartum antibiotics on the clinical spectrum of early-onset group B streptococcal infection in term infants. Pediatrics 2000;106:244-50.
62. Allen SR. Management of asymptomatic term neonates whose mothers received intrapartum antibiotics. Part 1: Rationale for intrapartum antibiotic therapy. Clin Pediatr 1997;36:563-8.
63. Allen SR. Management of asymptomatic term neonates whose mothers received intrapartum antibiotics. Part 2: Diagnostic tests and management strategies. Clin Pediatr 1997;36:617-24.
64. Siegel JD, Cushion NB. Prevention of early-onset group B streptococcal disease: Another look at single-dose penicillin at birth. Obstet Gynecol 1996;87:692-8.